Impact of Dopamine Replacement Therapy on Shame in Parkinson's Disease Patients

被引:0
作者
Chiuve, S. Catalano
Benis, D.
Zulet, A.
Krack, P.
Fleury, V.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
431
引用
收藏
页码:S183 / S183
页数:1
相关论文
共 50 条
[31]   A pilot psychometric study of aberrant salience state in patients with Parkinson’s disease and its association with dopamine replacement therapy [J].
Michele Poletti ;
Daniela Frosini ;
Cristina Pagni ;
Filippo Baldacci ;
Claudio Lucetti ;
Paolo Del Dotto ;
Roberto Ceravolo ;
Ubaldo Bonuccelli .
Neurological Sciences, 2014, 35 :1603-1605
[32]   The role of dopamine replacement on the behavioural phenotype of Parkinson's disease [J].
Alobaidi, Hajar ;
Pall, Hardev .
BEHAVIOURAL NEUROLOGY, 2013, 26 (04) :225-235
[33]   Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson's disease [J].
Alabrahim, Obaydah Abd Alkader ;
Azzazy, Hassan Mohamed El-Said .
NANOSCALE ADVANCES, 2022, 4 (24) :5233-5244
[34]   Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? [J].
Lawrence, AD ;
Evans, AH ;
Lees, AJ .
LANCET NEUROLOGY, 2003, 2 (10) :595-604
[35]   Behavioural Sensitisation During Dopamine Replacement Therapy in Parkinson's Disease is Reminiscent of the Addicted Brain [J].
Biagioni, F. ;
Pellegrini, A. ;
Ruggieri, S. ;
Murri, L. ;
Paparelli, A. ;
Fornai, F. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (10) :894-902
[36]   Dopamine replacement therapy normalizes reactive step length to postural perturbations in Parkinson?s disease [J].
Herbers, Cara ;
Schroeder, Joseph ;
Lu, Chiahao ;
Geng, Helen ;
Zhang, Raymond ;
Mehregan, Jessica ;
Malakowsky, Kada ;
Erdman, Arthur ;
Johnson, Matthew D. ;
Cooper, Scott E. .
GAIT & POSTURE, 2023, 101 :95-100
[37]   Early-stage cognitive impairment in Parkinson's disease and the influence of dopamine replacement therapy [J].
Miah, I. P. ;
Dubbelink, K. T. Olde ;
Stoffers, D. ;
Deijen, J. B. ;
Berendse, H. W. .
EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (03) :510-516
[38]   Adherence to once-daily dopamine agonists in levodopa-treated Parkinson's disease patients is related to first dopamine replacement therapy [J].
Santos-Garcia, D. ;
Prieto-Formoso, M. ;
de la Fuente-Fernandez, R. .
MOVEMENT DISORDERS, 2012, 27 :S50-S50
[39]   Impact of medication therapy management in patients with Parkinson's disease [J].
Henrichsmann, Martina ;
Hempel, Georg .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (01) :54-60
[40]   Impact of medication therapy management in patients with Parkinson's disease [J].
Henrichsmann, Martina ;
Hempel, Georg .
PHARMACEUTICAL CARE ESPANA, 2016, 18 (01) :51-51